Delivery Order SPE2DB22D1041-SPE2DB25FUBT4
- Not listed
- The Defense Logistics Agency awarded a $60,591.71 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90, with completion expected by September 5, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,915.76 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, with performance to take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $3,511.93. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $10,104.88. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and supports the federal...
- The Defense Logistics Agency awarded a $4,538.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The delivery order represents a continuation of the company's critical role as a pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $4,529.28 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) valued at $16,287.78. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. Performance will take place at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.90 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a completion date of July 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Candesartan cilexetil is an angiotensin receptor blocker used for...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBT4Delivery Order
The Defense Logistics Agency awarded a $3,867.24 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare programs. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. As a child contract under the SPE2DX vehicle, this award exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for the Department of Defense medical supply chain through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/4/25 |